ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 4 analysts with an average price target of $-3.61. This is a potential upside of $-7.91 (-183.95%) from yesterday's end of day stock price of $4.3.

Adverum Biotechnologies's activity chart (see below) currently has 31 price targets and 52 ratings on display. The stock rating distribution of ADVM is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.76% with an average time for these price targets to be met of 401.92 days.

Highest price target for ADVM is $12, Lowest price target is $4, average price target is $8.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 23-Sep-2025. First documented stock forecast 16-Jun-2015.

Currently out of the existing stock ratings of ADVM, 3 are a HOLD (25%), 9 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

1 months 10 days ago
(23-Sep-2025)

0/4 (0%)

$23.75 (380.00%)

Buy

2 months 20 days ago
(13-Aug-2025)

3/4 (75%)

$30.52 (321.94%)

884

Buy

$12

$7.7 (179.07%)

$16

4 months 8 days ago
(25-Jun-2025)

1/4 (25%)

$9.42 (365.12%)

292

Hold

$4

$-0.3 (-6.98%)

$5

5 months 18 days ago
(15-May-2025)

3/5 (60%)

$1.95 (95.12%)

127

Buy

$6

$4.05 (207.69%)

$4

2 years 1 months 29 days ago
(05-Sep-2023)

4/7 (57.14%)

$4.22 (237.08%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 401.92 days on average for the stock forecasts to be realized with a an average price target met ratio 74.76

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Charles Duncan has 14 price targets and 8 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $46.7

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Luca Issi with lowest potential downside - -$0.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?